OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease
Alexandre Vallée, Yves Lecarpentier, Rémy Guillevin, et al.
Acta Biochimica et Biophysica Sinica (2017) Vol. 49, Iss. 10, pp. 853-866
Open Access | Times Cited: 184

Showing 1-25 of 184 citing articles:

Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Sinemyiz Atalay, Iwona Jarocka-Karpowicz, Elżbieta Skrzydlewska
Antioxidants (2019) Vol. 9, Iss. 1, pp. 21-21
Open Access | Times Cited: 627

Cannabidiol Adverse Effects and Toxicity
Marilyn A. Huestis, Renata Solimini, Simona Pichini, et al.
Current Neuropharmacology (2019) Vol. 17, Iss. 10, pp. 974-989
Open Access | Times Cited: 369

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Serena Silvestro, Santa Mammana, Eugenio Cavalli, et al.
Molecules (2019) Vol. 24, Iss. 8, pp. 1459-1459
Open Access | Times Cited: 219

Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease
Xu Yan, Yue Hu, Biyao Wang, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 150

Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway
Alexandre Vallée
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2810-2810
Open Access | Times Cited: 87

The Polypharmacological Effects of Cannabidiol
Jorge Iván Castillo-Arellano, Ana Canseco-Alba, Stephen J. Cutler, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3271-3271
Open Access | Times Cited: 73

TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts
Alexandre Vallée, Yves Lecarpentier
Cell & Bioscience (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 141

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
Tommaso Cassano, Rosanna Villani, Lorenzo Pace, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 119

Neurogenesis After Stroke: A Therapeutic Perspective
Abir A. Rahman, Narayanappa Amruta, Emmanuel Pinteaux, et al.
Translational Stroke Research (2020) Vol. 12, Iss. 1, pp. 1-14
Open Access | Times Cited: 115

On the Neuroprotective Effects of Naringenin: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective
Zeinab Nouri, Sajad Fakhri, Fardous F. El‐Senduny, et al.
Biomolecules (2019) Vol. 9, Iss. 11, pp. 690-690
Open Access | Times Cited: 114

A systematic review of minor phytocannabinoids with promising neuroprotective potential
Nicole L. Stone, Alexandra J. Murphy, Timothy J. England, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 19, pp. 4330-4352
Open Access | Times Cited: 86

PPAR Gamma: From Definition to Molecular Targets and Therapy of Lung Diseases
Márcia V. de Carvalho, Cassiano Felippe Gonçalves-de-Albuquerque, Adriana Ribeiro Silva
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 805-805
Open Access | Times Cited: 74

Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease
Serena Silvestro, Giovanni Schepici, Placido Bramanti, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5186-5186
Open Access | Times Cited: 72

Single-cell RNA sequencing reveals B cell–related molecular biomarkers for Alzheimer’s disease
Liu‐Lin Xiong, Lu‐Lu Xue, Ruo‐Lan Du, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 12, pp. 1888-1901
Open Access | Times Cited: 68

Ginsenoside Rg1 improves Alzheimer's disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt/GSK‐3β/β‐catenin signaling pathway
Yi Yang, Wang Li-mei, Caijun Zhang, et al.
Chemical Biology & Drug Design (2022) Vol. 99, Iss. 6, pp. 884-896
Closed Access | Times Cited: 63

Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease
Ahsas Goyal, Aanchal Verma, Nandini Dubey, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 12
Closed Access | Times Cited: 48

Cannabidiol goes nuclear: The role of PPARγ
Sara Khosropoor, Mohaddeseh Sadat Alavi, Leila Etemad, et al.
Phytomedicine (2023) Vol. 114, pp. 154771-154771
Closed Access | Times Cited: 29

THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
Nicholas Pintori, Francesca Caria, Maria Antonietta De Luca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5251-5251
Open Access | Times Cited: 28

Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance
George Jîtcă, Bianca Eugenia Ősz, Camil-Eugen Vari, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 485-485
Open Access | Times Cited: 25

Warburg effect hypothesis in autism Spectrum disorders
Alexandre Vallée, Jean-Noël Vallée
Molecular Brain (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 80

Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
Gabriela Pandini Silote, Ariandra Guerini Sartim, Amanda J. Sales, et al.
Journal of Chemical Neuroanatomy (2019) Vol. 98, pp. 104-116
Closed Access | Times Cited: 76

Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis
Alexandre Vallée, Jean-Noël Vallée, Rémy Guillevin, et al.
Cellular and Molecular Neurobiology (2017) Vol. 38, Iss. 4, pp. 783-795
Closed Access | Times Cited: 72

Premature cell senescence in human skin: Dual face in chronic acquired pigmentary disorders
Barbara Bellei, Mauro Picardo
Ageing Research Reviews (2019) Vol. 57, pp. 100981-100981
Closed Access | Times Cited: 72

Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease
Blathnaid Hughes, Caroline E. Herron
Neurochemical Research (2018) Vol. 44, Iss. 3, pp. 703-713
Closed Access | Times Cited: 61

Page 1 - Next Page

Scroll to top